ClinicalTrials.Veeva

Menu

Effects of Omega-3 Fatty Acids and Menaquinone-7 on Thrombotic Tendency

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Completed

Conditions

Atherosclerosis

Treatments

Dietary Supplement: krill oil
Dietary Supplement: menaquinone-7
Dietary Supplement: fish oil

Study type

Interventional

Funder types

Other

Identifiers

NCT00732576
MEC 07-3-067

Details and patient eligibility

About

Omega-3 fatty acids are notably present in fish oil and krill oil, and are known to have beneficial effects on the vasculature. Vitamin K2 is known for preventing vascular calcification. In this study we investigate a potential synergy between the effects of either fish or krill oil and menaquinone-7, which is one of K2 vitamins.

Enrollment

57 patients

Sex

All

Ages

25 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy subjects - BMI < 30
  • written informed consent

Exclusion criteria

  • Use of oral anticoagulants
  • Coagulation disorders
  • Use of multivitamin supplements
  • Use of corticosteroids, anticonceptives
  • hypertriglyceridemia, hypercholesterolemia

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

57 participants in 8 patient groups

1
Active Comparator group
Description:
9 fish oil capsules, equivalent to 3 gram per day of n-3 polyunsaturated fatty acids (PUFA)
Treatment:
Dietary Supplement: fish oil
2
Active Comparator group
Description:
9 fish oil capsules, equivalent to 3 gram per day of n-3 polyunsaturated fatty acids (PUFA) including 1 capsule of menaquinone-7 per day (10 µg)
Treatment:
Dietary Supplement: fish oil
Dietary Supplement: menaquinone-7
3
Active Comparator group
Description:
9 fish oil capsules, equivalent to 3 gram per day of n-3 polyunsaturated fatty acids (PUFA) including 2 capsules of menaquinone-7 per day (20 µg per day)
Treatment:
Dietary Supplement: fish oil
Dietary Supplement: menaquinone-7
4
Active Comparator group
Description:
9 fish oil capsules, equivalent to 3 gram per day of n-3 polyunsaturated fatty acids (PUFA) including 1 capsule of menaquinone-7 per day (45 µg per day)
Treatment:
Dietary Supplement: fish oil
Dietary Supplement: menaquinone-7
5
Active Comparator group
Description:
9 krill oil capsules, equivalent to 1,5 gram per day of n-3 polyunsaturated fatty acids (PUFA)
Treatment:
Dietary Supplement: krill oil
6
Active Comparator group
Description:
9 krill oil capsules, equivalent to 1,5 gram per day of n-3 polyunsaturated fatty acids (PUFA) including 1 capsule of menaquinone-7 per day (10 µg)
Treatment:
Dietary Supplement: krill oil
Dietary Supplement: menaquinone-7
7
Active Comparator group
Description:
9 krill oil capsules, equivalent to 1,5 gram per day of n-3 polyunsaturated fatty acids (PUFA) including 2 capsules of menaquinone-7 per day (20 µg per day)
Treatment:
Dietary Supplement: krill oil
Dietary Supplement: menaquinone-7
8
Active Comparator group
Description:
9 krill oil capsules, equivalent to 1,5 gram per day of n-3 polyunsaturated fatty acids (PUFA) including 1 capsule of menaquinone-7 per day (45 µg per day)
Treatment:
Dietary Supplement: krill oil
Dietary Supplement: menaquinone-7

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems